论文部分内容阅读
1982年全国淋巴瘤协作组第三次会议(上海)修订洛阳方案,制定了“非何杰金氏恶性淋巴瘤工作分类”(简称上海分类)。我们按此方法对非何杰金氏恶性淋巴瘤进行了重新分类,并对我科1959～1980年间收治的142例恶性淋巴瘤的临床、病理与疗效作分析讨论。资料与方法本组142例恶性淋巴瘤均经病理切片证实。病理分类原系按传统分类方法,何杰金氏病(简称HD)26例,非何杰金氏恶性淋巴瘤 (简称NHL)116例(其中在外院行病理检查
In 1982, the third meeting of the National Lymphoma Cooperative Group (Shanghai) revised the Luoyang Plan and formulated the “Classification of Non-Hodgkin’s Lymphoma” (Shanghai Classification). According to this method, we reclassified non-Hodgkin’s lymphoma and discussed the clinical, pathological and therapeutic effects of 142 malignant lymphoma treated in our department from 1959 to 1980. Materials and Methods The group of 142 cases of malignant lymphoma confirmed by biopsy. According to the traditional classification of the original pathological classification, 26 cases of Hodgkin’s disease (referred to as HD), non-Hodgkin’s lymphoma (NHL) 116 cases (including pathological examination outside the hospital